Search

Search Constraints

You searched for: Author/Creator Gertz, Morie

Search Results

1. A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR‐CD) for untreated low‐grade non‐Hodgkin lymphoma requiring therapy. Issue 5 (22nd March 2017)

2. Clinical correlates and prognostic impact of clonal hematopoiesis in multiple myeloma patients receiving post‐autologous stem cell transplantation lenalidomide maintenance therapy. Issue 5 (23rd February 2021)

3. Cutaneous involvement in multiple myeloma: a multi-institutional retrospective study of 53 patients. Issue 9 (1st September 2016)

4. Exploring the amyloid proteome in immunoglobulin‐derived lymph node amyloidosis using laser microdissection/tandem mass spectrometry. Issue 7 (30th May 2013)

5. Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines. (2nd January 2022)

6. Impact of prior melphalan exposure on stem cell collection in light chain amyloidosis. (March 2018)

7. Implications of detecting serum monoclonal protein by MASS‐fix following stem cell transplantation in multiple myeloma. (20th November 2020)

9. Long‐term results of the phase II trial of the oral mTOR inhibitor everolimus (RAD001) in relapsed or refractory Waldenstrom Macroglobulinemia. Issue 3 (March 2014)

10. Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis. Issue 5 (27th February 2019)